Boston Angel Investors →
Partner, Third Rock Ventures
Founder, The Haul Company
CEO of Project Foundry
Founder and Chairman, Sycamore Networks
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
CEO and co-founder of BoostSuite
Managing director, the Foundry Group
March 28, 2017 ·
April 19, 2017 ·
May 11, 2017 ·
Ascent Therapeutics, based in Cambridge, MA, is developing a new class of drugs to target cell surface receptors involved in many diseases.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.